SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-047129
Filing Date
2022-08-12
Accepted
2022-08-12 10:04:35
Documents
14
Period of Report
2022-08-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164299-8k_edocacq.htm   iXBRL 8-K 37621
2 PRESS RELEASE, DATED AUGUST 12, 2022 ea164299ex99-1_edocacq.htm EX-99.1 9338
  Complete submission text file 0001213900-22-047129.txt   280671

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adoc-20220812.xsd EX-101.SCH 4134
4 XBRL DEFINITION FILE adoc-20220812_def.xml EX-101.DEF 27309
5 XBRL LABEL FILE adoc-20220812_lab.xml EX-101.LAB 37859
6 XBRL PRESENTATION FILE adoc-20220812_pre.xml EX-101.PRE 25929
8 EXTRACTED XBRL INSTANCE DOCUMENT ea164299-8k_edocacq_htm.xml XML 7147
Mailing Address 7612 MAIN STREET FISHERS SUITE 200 VICTOR NY 14564
Business Address 7612 MAIN STREET FISHERS SUITE 200 VICTOR NY 14564 5856781198
Edoc Acquisition Corp. (Filer) CIK: 0001824884 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39689 | Film No.: 221158359
SIC: 2836 Biological Products, (No Diagnostic Substances)